echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Pfizer deploys innovative protein degradation technology to selectively target tumor tissues

    Pfizer deploys innovative protein degradation technology to selectively target tumor tissues

    • Last Update: 2022-01-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On November 29, 2021, Ranok Therapeutics announced an agreement with Pfizer to use the company’s proprietary molecular chaperone-mediated targeted protein degradation (CHAMP) technology platform to target an undisclosed Of cancer targets to develop innovative therapies


    In recent years, targeted protein degradation has become a new direction in the development of small molecule drugs


    In some cases, the chaperone can bind to E3 ubiquitin ligase and mediate the degradation of the substrate by the proteasome


    ▲Principle of CHAMP technology platform (picture source: Shunuo Biological official website)

    Through this platform, Pinnacle Biosciences develops innovative drugs needed for tumors and other major diseases, improves the long-term quality of life of patients, and satisfies unmet clinical needs.


    Reference materials:

    [1] Ranok Therapeutics Announces Agreement with Pfizer on Targeted Protein Degradation.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.